Profusa, Inc. (PFSA)

ASLAN Pharmaceuticals Statistics

Total Valuation

Profusa has a market cap or net worth of $18.48 million. The enterprise value is $66.40 million.

Market Cap	18.48M
Enterprise Value	66.40M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Profusa has 33.00 million shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class	33.00M
Shares Outstanding	33.00M
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.37%
Owned by Institutions (%)	1.00%
Float	25.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.62
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	885.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.12%
Revenue Per Employee	$5,000
Profits Per Employee	-$637,400
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.09
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	30.51
Average Volume (20 Days)	7,973,144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Profusa had revenue of $75,000 and -$9.56 million in losses. Loss per share was -$1.71.

Revenue	75,000
Gross Profit	75,000
Operating Income	-4.61M
Pretax Income	n/a
Net Income	-9.56M
EBITDA	n/a
EBIT	-4.61M
Loss Per Share	-$1.71

Balance Sheet

The company has $19,000 in cash and $50.25 million in debt, giving a net cash position of -$50.23 million or -$1.52 per share.

Cash & Cash Equivalents	19,000
Total Debt	50.25M
Net Cash	-50.23M
Net Cash Per Share	-$1.52
Equity (Book Value)	-56.77M
Book Value Per Share	-21.75
Working Capital	-59.90M

Cash Flow

Operating Cash Flow	-1.86M
Capital Expenditures	n/a
Free Cash Flow	-1.86M
FCF Per Share	-$0.06

Margins

Gross Margin	100.00%
Operating Margin	-6,146.67%
Pretax Margin	-12,748.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Profusa does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.23%
Shareholder Yield	-0.23%
Earnings Yield	-59.12%
FCF Yield	-11.51%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Profusa has an Altman Z-Score of -81.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-81.36
Piotroski F-Score	1